RNA-inhibiting small molecules for neurological diseases (Arrakis Therapeutics)

N/A

Report date: 2025/01/26 17:03:43
NME

Base Information

Drug NameRNA-inhibiting small molecules for neurological diseases (Arrakis Therapeutics)
Drug Alias NameRNA-targeted small molecules for neurological diseases(Arrakis Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA modulators
TargetsRibonucleic Acid
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrakis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrakis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A